• 主页
  • 查找结果
  • Mitochondrial iron accumulation exacerbates hepatic toxicity caused by hepatitis C virus core protein.

Mitochondrial iron accumulation exacerbates hepatic toxicity caused by hepatitis C virus core protein.

Toxicology and applied pharmacology (2014-12-30)
Shuichi Sekine, Konomi Ito, Haruna Watanabe, Takafumi Nakano, Kyoji Moriya, Yoshizumi Shintani, Hajime Fujie, Takeya Tsutsumi, Hideyuki Miyoshi, Hidetake Fujinaga, Seiko Shinzawa, Kazuhiko Koike, Toshiharu Horie
摘要

Patients with long-lasting hepatitis C virus (HCV) infection are at major risk of hepatocellular carcinoma (HCC). Iron accumulation in the livers of these patients is thought to exacerbate conditions of oxidative stress. Transgenic mice that express the HCV core protein develop HCC after the steatosis stage and produce an excess of hepatic reactive oxygen species (ROS). The overproduction of ROS in the liver is the net result of HCV core protein-induced dysfunction of the mitochondrial respiratory chain. This study examined the impact of ferric nitrilacetic acid (Fe-NTA)-mediated iron overload on mitochondrial damage and ROS production in HCV core protein-expressing HepG2 (human HCC) cells (Hep39b cells). A decrease in mitochondrial membrane potential and ROS production were observed following Fe-NTA treatment. After continuous exposure to Fe-NTA for six days, cell toxicity was observed in Hep39b cells, but not in mock (vector-transfected) HepG2 cells. Moreover, mitochondrial iron ((59)Fe) uptake was increased in the livers of HCV core protein-expressing transgenic mice. This increase in mitochondrial iron uptake was inhibited by Ru360, a mitochondrial Ca(2+) uniporter inhibitor. Furthermore, the Fe-NTA-induced augmentation of mitochondrial dysfunction, ROS production, and cell toxicity were also inhibited by Ru360 in Hep39b cells. Taken together, these results indicate that Ca(2+) uniporter-mediated mitochondrial accumulation of iron exacerbates hepatocyte toxicity caused by the HCV core protein.

材料
货号
品牌
产品描述

Sigma-Aldrich
十二烷基硫酸钠, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
十二烷基硫酸钠, ACS reagent, ≥99.0%
Sigma-Aldrich
十二烷基硫酸钠, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
硝酸铁(III) 九水合物, ACS reagent, ≥98%
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
腺嘌呤, ≥99%
Sigma-Aldrich
十二烷基硫酸钠, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
铁, ≥99%, reduced, powder (fine)
Sigma-Aldrich
硝酸铁(III) 九水合物, ≥99.95% trace metals basis
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
十二烷基硫酸钠, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
次氮基三乙酸, Sigma Grade, ≥99%
Sigma-Aldrich
十二烷基硫酸钠, 92.5-100.5% based on total alkyl sulfate content basis
Supelco
十二烷基硫酸钠, suitable for ion pair chromatography, LiChropur, ≥99.0%
Sigma-Aldrich
腺嘌呤, BioReagent, suitable for cell culture
Supelco
十二烷基硫酸钠, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
硝酸铁(III) 九水合物, BioReagent, suitable for cell culture
Sigma-Aldrich
十二烷基硫酸钠, ≥90%
Sigma-Aldrich
铁, powder, −325 mesh, 97%
Sigma-Aldrich
羰基铁, ≥97% Fe basis
Sigma-Aldrich
JC-1, solid
Sigma-Aldrich
铁, powder, <10 μm, ≥99.9% trace metals basis
Sigma-Aldrich
十二烷基硫酸钠, ≥98.0% (GC)
Sigma-Aldrich
铁, puriss. p.a., carbonyl-Iron powder, low in magnesium and manganese compounds, ≥99.5% (RT)
Supelco
依地酸盐二钠杂质A, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
次氮基三乙酸, ACS reagent, ≥99.0%
Sigma-Aldrich
铁, flakes, ≥99.99% trace metals basis
Sigma-Aldrich
次氮基三乙酸 三钠盐, Sigma Grade, ≥98%
Sigma-Aldrich
铁, nanopowder, 35-45 nm particle size, 99.5% trace metals basis

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。